D. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathologica, vol.45, issue.6, pp.803-820, 2016.
DOI : 10.1007/s00401-016-1545-1
URL : https://hal.archives-ouvertes.fr/hal-01479018

R. Stupp, W. Mason, M. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

O. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., Bevacizumab plus Radiotherapy???Temozolomide for Newly Diagnosed Glioblastoma, New England Journal of Medicine, vol.370, issue.8, pp.709-722, 2014.
DOI : 10.1056/NEJMoa1308345
URL : http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-89503

M. Gilbert, E. Sulman, and M. Mehta, Bevacizumab for newly diagnosed glioblastoma, N Engl J Med, vol.370, pp.2048-2049, 2014.
DOI : 10.1056/nejmoa1308573
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201043

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

S. Fulda and D. Vucic, Targeting IAP proteins for therapeutic intervention in cancer, Nature Reviews Drug Discovery, vol.2, issue.2, pp.109-124, 2012.
DOI : 10.1038/nrd3627

A. Chakravarti, E. Noll, P. Black, D. Finkelstein, D. Finkelstein et al., Quantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas, Journal of Clinical Oncology, vol.20, issue.4, pp.1063-1068, 2002.
DOI : 10.1200/JCO.2002.20.4.1063

Y. Shi, W. Ding, J. Zhou, J. He, Y. Xu et al., Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence, Hepatology, vol.7, issue.2, pp.497-507, 2008.
DOI : 10.1002/hep.22393

R. Feltham, N. Khan, J. Silke, . Iaps, and . Ubiquitylation, IAPS and ubiquitylation, IUBMB Life, vol.17, issue.5, pp.411-418, 2012.
DOI : 10.1002/iub.565
URL : http://arrow.latrobe.edu.au:8080/vital/access/manager/Repository/latrobe:13917/SOURCE01

J. Flygare, M. Beresini, N. Budha, H. Chan, I. Chan et al., Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152), Journal of Medicinal Chemistry, vol.55, issue.9, pp.4101-4113, 2012.
DOI : 10.1021/jm300060k

M. Preusser, E. Gelpi, R. Matej, C. Marosi, K. Dieckmann et al., No prognostic impact of survivin expression in glioblastoma, Acta Neuropathologica, vol.Neurochir, issue.5, pp.534-538, 2005.
DOI : 10.1007/s00401-005-0992-x

C. Jiguet-jiglaire, M. Cayol, S. Mathieu, C. Jeanneau, C. Bouvier-labit et al., Noninvasive near-infrared fluorescent protein-based imaging of tumor progression and metastases in deep organs and intraosseous tissues, Journal of Biomedical Optics, vol.19, issue.1, p.16019, 2014.
DOI : 10.1117/1.JBO.19.1.016019

C. Hsieh, Y. Lin, C. Wu, H. Lee, W. Shyu et al., Livin Contributes to Tumor Hypoxia-Induced Resistance to Cytotoxic Therapies in Glioblastoma Multiforme, Clinical Cancer Research, vol.21, issue.2, pp.460-470, 2015.
DOI : 10.1158/1078-0432.CCR-14-0618

J. Zhou, N. Yuen, Q. Zhan, E. Velazquez, G. Murphy et al., Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma, Cancer Immunology, Immunotherapy, vol.363, issue.5, pp.655-665, 2012.
DOI : 10.1007/s00262-011-1124-1

P. Gazzaniga, A. Gradilone, L. Giuliani, O. Gandini, I. Silvestri et al., Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer, Annals of Oncology, vol.14, issue.1, pp.85-90, 2003.
DOI : 10.1093/annonc/mdg002

D. Kim, C. Alvarado, C. Abramowsky, L. Gu, M. Zhou et al., Expression of Inhibitor-of-Apoptosis Protein (IAP) Livin by Neuroblastoma Cells: Correlation with Prognostic Factors and Outcome, Pediatric and Developmental Pathology, vol.18, issue.6, pp.621-629, 2005.
DOI : 10.1007/s10024-005-4108-3

H. Tanabe, A. Yagihashi, N. Tsuji, Y. Shijubo, S. Abe et al., Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer, Lung Cancer, vol.46, issue.3, pp.299-304, 2004.
DOI : 10.1016/j.lungcan.2004.05.002

H. Takeuchi, J. Kim, A. Fujimoto, N. Umetani, T. Mori et al., X-Linked Inhibitor of Apoptosis Protein Expression Level in Colorectal Cancer Is Regulated by Hepatocyte Growth Factor/C-Met Pathway via Akt Signaling, Clinical Cancer Research, vol.11, issue.21, pp.7621-7628, 2005.
DOI : 10.1158/1078-0432.CCR-05-0479

Y. Xiang, H. Yao, S. Wang, M. Hong, J. He et al., Prognostic Value of Survivin and Livin in Nasopharyngeal Carcinoma, The Laryngoscope, vol.113, issue.1, pp.126-130, 2006.
DOI : 10.1097/01.mlg.0000187392.87904.35

H. Takeuchi, D. Morton, D. Elashoff, and D. Hoon, Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine, International Journal of Cancer, vol.60, issue.6, pp.1032-1038, 2005.
DOI : 10.1002/ijc.21267

R. Berger, C. Jennewein, V. Marschall, S. Karl, S. Cristofanon et al., NF-??B Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for ??-Irradiation-Induced Apoptosis, Molecular Cancer Therapeutics, vol.10, issue.10, pp.1867-1875, 2011.
DOI : 10.1158/1535-7163.MCT-11-0218

L. Wagner, V. Marschall, S. Karl, S. Cristofanon, K. Zobel et al., Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-??B-dependent manner, Oncogene, vol.10, issue.8, pp.988-997, 2013.
DOI : 10.1038/onc.2012.108

S. Cristofanon, B. Abhari, M. Krueger, A. Tchoghandjian, S. Momma et al., Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis, Cell Death and Disease, vol.57, issue.4, p.1724, 2015.
DOI : 10.1038/onc.2011.614

R. Hu, J. Li, Z. Liu, M. Miao, and K. Yao, GDC-0152 induces apoptosis through down-regulation of IAPs in human leukemia cells and inhibition of PI3K/Akt signaling pathway, Tumor Biology, vol.6, issue.3, pp.577-584, 2015.
DOI : 10.1007/s13277-014-2648-8

L. Yang, T. Shu, Y. Liang, W. Gu, C. Wang et al., GDC-0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway, International Journal of Oncology, vol.46, pp.1651-1658, 2015.
DOI : 10.3892/ijo.2015.2872

A. Tchoghandjian, C. Jennewein, I. Eckhardt, S. Momma, D. Figarella-branger et al., Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-??B, Cell Death and Differentiation, vol.19, issue.5, pp.735-747, 2014.
DOI : 10.1111/j.1582-4934.2009.00888.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978303/

A. Tchoghandjian, N. Baeza-kallee, C. Beclin, P. Metellus, C. Colin et al., Cortical and Subventricular Zone Glioblastoma-Derived Stem-Like Cells Display Different Molecular Profiles and Differential In Vitro and In Vivo Properties, Annals of Surgical Oncology, vol.70, issue.5, pp.608-619, 2012.
DOI : 10.1245/s10434-011-2093-5
URL : https://hal.archives-ouvertes.fr/hal-00839131

A. Tchoghandjian, N. Baeza, C. Colin, M. Cayre, P. Metellus et al., A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties, Brain Pathology, vol.4, issue.1, pp.211-221, 2010.
DOI : 10.1111/j.1750-3639.2009.00269.x
URL : https://hal.archives-ouvertes.fr/hal-00507521

E. Denicolai, N. Baeza-kallee, A. Tchoghandjian, M. Carre, C. Colin et al., Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo, Oncotarget, vol.5, issue.21, pp.10934-10948, 2014.
DOI : 10.18632/oncotarget.2541

U. Heinicke, J. Kupka, I. Fichter, and S. Fulda, Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma, Oncogene, vol.57, issue.28, pp.3729-3741, 2015.
DOI : 10.1038/sj.bjc.6605642

I. Nicoletti, G. Migliorati, M. Pagliacci, F. Grignani, and C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry, Journal of Immunological Methods, vol.139, issue.2, pp.271-279, 1991.
DOI : 10.1016/0022-1759(91)90198-O

T. Nguyen, J. Oberholzer, J. Birraux, P. Majno, P. Morel et al., Highly Efficient Lentiviral Vector-Mediated Transduction of Nondividing, Fully Reimplantable Primary Hepatocytes, Molecular Therapy, vol.6, issue.2, pp.199-209, 2002.
DOI : 10.1006/mthe.2002.0653

S. Mathieu, M. Prorok, A. Benoliel, R. Uch, C. Langlet et al., Transgene Expression of ??(1,2)-Fucosyltransferase-I (FUT1) in Tumor Cells Selectively Inhibits Sialyl-Lewis x Expression and Binding to E-Selectin without Affecting Synthesis of Sialyl-Lewis a or Binding to P-Selectin, The American Journal of Pathology, vol.164, issue.2, pp.371-383, 2004.
DOI : 10.1016/S0002-9440(10)63127-6

R. Erickson, J. Tarrant, G. Cain, S. Lewin-koh, N. Dybdal et al., Toxicity Profile of Small-Molecule IAP Antagonist GDC-0152 Is Linked to TNF-?? Pharmacology, Toxicological Sciences, vol.131, issue.1, pp.247-258, 2013.
DOI : 10.1093/toxsci/kfs265

H. Wong, N. Budha, K. West, E. Blackwood, J. Ware et al., Dogs Are More Sensitive to Antagonists of Inhibitor of Apoptosis Proteins Than Rats and Humans: A Translational Toxicokinetic/Toxicodynamic Analysis, Toxicological Sciences, vol.130, issue.1, pp.205-213, 2012.
DOI : 10.1093/toxsci/kfs235

G. Filonov, K. Piatkevich, L. Ting, J. Zhang, K. Kim et al., Bright and stable near-infrared fluorescent protein for in vivo imaging, Nature Biotechnology, vol.24, issue.2, pp.757-761, 2011.
DOI : 10.1083/jcb.200308104